Abstract
Irritable bowel syndrome (IBS) is a common functional bowel disorder. Up to 96% of IBS patients experience bloating, resulting in poor response to conventional therapies and high consultation rates. Many IBS patients report that food triggers symptoms, particularly diets with poorly absorbed, short-chain carbohydrates, and restrict intake of certain foods to control their symptoms. IBS patients are especially susceptible to an attack due to visceral hypersensitivity. An emerging therapeutic strategy excludes fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) from the diet. There is evidence supporting the efficacy of a low FODMAP diet in improving symptoms of bloating in IBS patients. Individualised, structured dietary guidance may benefit those with persistent troublesome symptoms despite traditional therapies. In view of the multifactorial aetiology of the condition, it is probably best to use a multipronged approach, involving combination therapies, to address bloating in IBS patients.
TY - JOUR
T1 - Restriction of FODMAP in the management of bloating in irritable bowel syndrome.
A1 - Wong,Wei Mon,
PY - 2016/9/25/entrez
PY - 2016/9/25/pubmed
PY - 2017/8/5/medline
KW - FODMAPs
KW - bloating
KW - irritable bowel syndrome
KW - low FODMAP diet
SP - 476
EP - 84
JF - Singapore medical journal
JO - Singapore Med J
VL - 57
IS - 9
N2 - Irritable bowel syndrome (IBS) is a common functional bowel disorder. Up to 96% of IBS patients experience bloating, resulting in poor response to conventional therapies and high consultation rates. Many IBS patients report that food triggers symptoms, particularly diets with poorly absorbed, short-chain carbohydrates, and restrict intake of certain foods to control their symptoms. IBS patients are especially susceptible to an attack due to visceral hypersensitivity. An emerging therapeutic strategy excludes fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) from the diet. There is evidence supporting the efficacy of a low FODMAP diet in improving symptoms of bloating in IBS patients. Individualised, structured dietary guidance may benefit those with persistent troublesome symptoms despite traditional therapies. In view of the multifactorial aetiology of the condition, it is probably best to use a multipronged approach, involving combination therapies, to address bloating in IBS patients.
SN - 0037-5675
UR - https://www.unboundmedicine.com/medline/citation/27664186/Restriction_of_FODMAP_in_the_management_of_bloating_in_irritable_bowel_syndrome_
L2 - http://dx.doi.org/10.11622/smedj.2016152
DB - PRIME
DP - Unbound Medicine
ER -